开发一种风险预测模型,用于菌素相关的急性损伤:一个多中心的回顾性研究
Tomoyuki Ishigo1, Ayako Suzuki2,3,4, Yuta Ibe1
1Department of Pharmacy, Sapporo Medical University Hospital, Sapporo, Japan.
The Journal of antimicrobial chemotherapy
|February 4, 2026
概括
这项研究发现,在患有不同功能的万科米辛患者中,急性损伤 (AKI) 风险没有差异. 一个新的AKI风险评分是基于药物暴露和其他药物的基础上开发的.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
背景情况:
- 急性损伤 (AKI) 是接受万科米的患者的一个重大问题.
- 了解风险因素对于米素相关的AKI至关重要,特别是在功能受损的患者中.
- 在这一群体中,AKI现有的风险分层需要进一步改进.
研究的目的:
- 在不同程度的功能障碍患者中调查范科米辛使用和AKI之间的关系.
- 开发和验证一种可预测的AKI风险评分,用于治疗Vancomycin的患者.
- 为了评估基线功能是否会影响万科米辛治疗期间的AKI发病率.
主要方法:
- 追溯性,多中心,观察性队列研究设计.
- 对万科米辛血中最低和最高水平的分析,以及估计的淋巴细胞过率 (eGFR).
- 基于对AKI预测指标的Cox比例危险分析的风险评分的开发.
主要成果:
- 开始使用万科米辛后14天内AKI的总发病率为11.7%.
- 在EGFR类别 (≥60,30-59,<30毫升/分钟/1.73米2) 中,没有观察到AKI累积发病率的统计学上显著差异.
- 关键的AKI预测因素包括同时使用tazobactam/piperacillin,血管压缩剂/诺托普药物,以及第二天度-时间曲线 (AUC) 暴露下的更高的万科米辛区域.
结论:
- 成功开发了一种针对AKI的新型风险预测模型,该模型结合了万科米辛AUC暴露和同时服用的药物.
- 该研究表明,基线功能类别没有显著改变发展AKI的风险.
- 开发的风险评分可以帮助识别患有AKI风险较高的患者,从而实现有针对性的监测和干预.
相关概念视频
01:22Acute Kidney Injury I: Introduction
756
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
756
01:29Acute Kidney Injury II: Pathophysiology
1.1K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.1K
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
341
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
341
01:22Acute Kidney Injury VI: Nursing Management
481
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
481
01:20Acute Kidney Injury V: Interprofessional Care
362
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
362
01:29Acute Kidney Injury III: Clinical Manifestations
950
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
950